Search results
Results from the Tech24 Deals Content Network
Optimer Pharmaceuticals, Inc. was founded in 1998 and registered in the state of Delaware. Corporate and R&D headquarters were located in San Diego, California until 2011. CEO Michael Nientse Chang founded, funded and built the company with his wife, Tessie Mary Che, who was COO from 1998 to 2011. From 2007 to 2013, Optimer Pharmaceuticals was ...
Optimer structure with non target binding groups removed for improved Optimer performance and manufacturability. Optimer ligands are short synthetic oligonucleotide molecules composed of DNA or RNA that bind to a specific target molecule. They are engineered to bind their target molecules with affinity typically in the low nanomolar range. [1]
It was formerly a subsidiary of Optimer Pharmaceuticals. On 9 Feb 2007, its parent company Optimer Pharmaceuticalscan buy/sell on Nasdaq Stock Exchange. At that time, its share price was US$8.50 per share. On 15 May 2012, OBI Pharma, Inc. was approved to become a public company in Taiwan. On 23 Mar 2015, it can do transaction formally on OTC in ...
You can find instant answers on our AOL Mail help page. Should you need additional assistance we have experts available around the clock at 800-730-2563.
Optimer Pharmaceuticals (NAS: OPTR) is expected to report Q1 earnings around May 3. Here's what Wall Street wants to see: The 10-second takeaway Comparing the upcoming quarter to the prior-year ...
1-800-358-4860. Get live expert help with your AOL needs—from email and passwords, technical questions, mobile email and more.
Use Sign-in Helper, AOL's password reset and account recovery tool, to get back in to your account. Go to the Sign-in Helper. Enter one of the account recovery items listed. Click Continue. Follow the instructions given in the Sign-in Helper. Change your password. From a desktop or mobile web browser: Sign in to the AOL Account security page.
Optimer Pharmaceuticals (NAS: OPTR) reported earnings on Nov. 1. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Sep. 30 (Q3), Optimer Pharmaceuticals beat ...